Puma Biotechnology, Inc.
US ˙ NasdaqGS ˙ US74587V1070

SecurityPBYI / Puma Biotechnology, Inc.
InstitutionBarclays Plc
Latest Disclosed Ownership81,434 shares
Latest Disclosed Value $ 484,533
Barclays Plc ownership in PBYI / Puma Biotechnology, Inc.

On February 13, 2026 - Barclays Plc filed a 13F-HR form disclosing ownership of 81,434 shares of Puma Biotechnology, Inc. (US:PBYI) valued at $484,532 USD as of December 31, 2025. The entity filed a previous 13F-HR/A on March 31, 2026 disclosing 79,881 shares of Puma Biotechnology, Inc.. This represents a change in shares of 1.94% during the quarter. The current value of the position is $572,481 USD.

Barclays Plc has a history of taking positions in derivatives of the underlying security (PBYI) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

PBYI / Puma Biotechnology, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-02-13 2025-12-31 13F PUMA BIOTECHNOLOGY COM 74587V107 81,434 1,553 1.94 485 14.15 0.0001
2026-03-31 2025-09-30 13F/A-3 PUMA BIOTECHNOLOGY COM 74587V107 79,881 -28,772 -26.48 424 13.98 0.0001
2026-03-19 2025-09-30 13F/A-2 PUMA BIOTECHNOLOGY COM 74587V107 78,021 -30,632 199 0.0001
2025-11-12 2025-09-30 13F PUMA BIOTECHNOLOGY COM 74587V107 79,881 -28,772 424 0.0001
2026-02-27 2025-06-30 13F/A-2 PUMA BIOTECHNOLOGY COM 74587V107 108,653 25,392 30.50 373 51.22 0.0001
2025-08-14 2025-06-30 13F/A-1 PUMA BIOTECHNOLOGY COM 74587V107 108,653 25,392 0 0.0001
2025-08-13 2025-06-30 13F PUMA BIOTECHNOLOGY COM 74587V107 108,653 25,392 0 0.0000
2026-03-17 2025-03-31 13F/A-1 PUMA BIOTECHNOLOGY COM 74587V107 83,261 -5,146 -5.82 246 -8.55 0.0001
2025-05-15 2025-03-31 13F PUMA BIOTECHNOLOGY COM 74587V107 83,261 -5,146 0 0.0001
2026-03-19 2024-12-31 13F/A-1 PUMA BIOTECHNOLOGY COM 74587V107 88,407 10,386 13.31 270 35.86 0.0001
2025-02-13 2024-12-31 13F PUMA BIOTECHNOLOGY COM 74587V107 88,407 10,386 0 0.0001
2026-03-31 2024-09-30 13F/A-2 PUMA BIOTECHNOLOGY COM 74587V107 78,021 46,370 146.50 199 92.23 0.0001
2024-11-19 2024-09-30 13F/A-1 PUMA BIOTECHNOLOGY COM 74587V107 78,021 46,370 0 0.0001
2024-11-15 2024-09-30 13F PUMA BIOTECHNOLOGY COM 74587V107 78,021 46,370 0 0.0000
2026-03-23 2024-06-30 13F/A-1 PUMA BIOTECHNOLOGY COM 74587V107 31,651 14,327 82.70 103 13.19 0.0000
2024-08-14 2024-06-30 13F PUMA BIOTECHNOLOGY COM 74587V107 31,651 14,327 0 0.0000
2026-03-24 2024-03-31 13F/A-1 PUMA BIOTECHNOLOGY COM 74587V107 17,324 0 0.00 92 21.33 0.0000
2024-05-15 2024-03-31 13F PUMA BIOTECHNOLOGY COM 74587V107 17,324 0 0 0.0000
2026-03-25 2023-12-31 13F/A-1 PUMA BIOTECHNOLOGY COM 74587V107 17,324 -1,961 -10.17 75 50.00 0.0000
2024-02-15 2023-12-31 13F PUMA BIOTECHNOLOGY COM 74587V107 17,324 -1,961 0 0.0000
2026-03-26 2023-09-30 13F/A-1 PUMA BIOTECHNOLOGY COM 74587V107 19,285 1,945 11.22 51 -18.03 0.0000
2023-11-07 2023-09-30 13F PUMA BIOTECHNOLOGY COM 74587V107 19,285 1,945 0 0.0000
2026-03-30 2023-06-30 13F/A-2 PUMA BIOTECHNOLOGY COM 74587V107 17,340 42 0.24 61 15.09 0.0000
2023-09-20 2023-06-30 13F/A-1 PUMA BIOTECHNOLOGY COM 74587V107 17,340 42 0 0.0000
2023-08-03 2023-06-30 13F PUMA BIOTECHNOLOGY COM 74587V107 17,340 42 0 0.0000
2026-03-30 2023-03-31 13F/A-1 PUMA BIOTECHNOLOGY COM 74587V107 17,298 0 0.00 53 -27.40 0.0000
2023-05-04 2023-03-31 13F PUMA BIOTECHNOLOGY COM 74587V107 17,298 0 0 0.0000
2026-03-30 2022-12-31 13F/A-1 PUMA BIOTECHNOLOGY COM 74587V107 17,298 -36,812 -68.03 73 -43.41 0.0000
2023-02-13 2022-12-31 13F PUMA BIOTECHNOLOGY COM 74587V107 17,298 -36,812 0 0.0000
2022-11-03 2022-09-30 13F PUMA BIOTECHNOLOGY COM 74587V107 54,110 -2,956 -5.18 129 -20.86 0.0001
2022-08-12 2022-06-30 13F PUMA BIOTECHNOLOGY COM 74587V107 57,066 -5,242 -8.41 163 -9.94 0.0001
2022-05-16 2022-03-31 13F PUMA BIOTECHNOLOGY COM 74587V107 62,308 -24,379 -28.12 181 -31.18 0.0001
2022-02-23 2021-12-31 13F/A-1 PUMA BIOTECHNOLOGY COM 74587V107 86,687 23,044 36.21 263 -41.03 0.0001
2022-02-14 2021-12-31 13F PUMA BIOTECHNOLOGY COM 74587V107 86,687 23,044 263 0.0000
2021-11-09 2021-09-30 13F PUMA BIOTECHNOLOGY COM 74587V107 63,643 13,112 25.95 446 -3.67 0.0002
2021-08-13 2021-06-30 13F PUMA BIOTECHNOLOGY COM 74587V107 50,531 -13,818 -21.47 463 -25.92 0.0002
2021-05-13 2021-03-31 13F PUMA BIOTECHNOLOGY COM 74587V107 64,349 -14,583 -18.48 625 -22.84 0.0003
2021-02-11 2020-12-31 13F PUMA BIOTECHNOLOGY COM 74587V107 78,932 -23,283 -22.78 810 -21.51 0.0004
2020-11-12 2020-09-30 13F PUMA BIOTECHNOLOGY COM 74587V107 102,215 -10,946 -9.67 1,032 -12.54 0.0006
2020-08-12 2020-06-30 13F PUMA BIOTECHNOLOGY COM 74587V107 113,161 10,730 10.48 1,180 36.57 0.0009
2020-05-13 2020-03-31 13F PUMA BIOTECHNOLOGY COM 74587V107 102,431 12,499 13.90 864 9.78 0.0007
2020-02-10 2019-12-31 13F PUMA BIOTECHNOLOGY COM 74587V107 89,932 -4,543 -4.81 787 -22.54 0.0004
2019-11-15 2019-09-30 13F/A-1 PUMA BIOTECHNOLOGY COM 74587V107 94,475 34,445 57.38 1,016 33.16 0.0006
2019-11-14 2019-09-30 13F PUMA BIOTECHNOLOGY COM 74587V107 94,475 34,445 1,016 234.9003
2019-08-14 2019-06-30 13F PUMA BIOTECHNOLOGY COM 74587V107 60,030 32,567 118.59 763 -28.36 0.0005
2019-05-15 2019-03-31 13F PUMA BIOTECHNOLOGY COM 74587V107 27,463 204 0.75 1,065 91.89 0.0007
2019-02-14 2018-12-31 13F PUMA BIOTECHNOLOGY COM 74587V107 27,259 -100,852 -78.72 555 -90.55 0.0004
2018-11-14 2018-09-30 13F PUMA BIOTECHNOLOGY COM 74587V107 128,111 117,687 1,129.00 5,875 853.73 0.0041
2018-08-14 2018-06-30 13F PUMA BIOTECHNOLOGY COM 74587V107 10,424 -3,667 -26.02 616 -35.77 0.0005
2018-05-15 2018-03-31 13F PUMA BIOTECHNOLOGY COM 74587V107 14,091 -45,614 -76.40 959 -83.75 0.0007
2018-02-14 2017-12-31 13F PUMA BIOTECHNOLOGY COM 74587V107 59,705 -127,844 -68.17 5,901 -73.73 0.0048
2017-11-14 2017-09-30 13F PUMA BIOTECHNOLOGY COM 74587V107 187,549 103,487 123.11 22,460 205.70 0.0231
2017-08-14 2017-06-30 13F PUMA BIOTECHNOLOGY COM 74587V107 84,062 17,400 26.10 7,347 196.25 0.0079
2017-05-15 2017-03-31 13F PUMA BIOTECHNOLOGY COM 74587V107 66,662 61,153 1,110.06 2,480 1,367.46 0.0027
2017-02-14 2016-12-31 13F PUMA BIOTECHNOLOGY COM 74587V107 5,509 5,132 1,361.27 169 576.00 0.0002
2016-11-14 2016-09-30 13F PUMA BIOTECHNOLOGY COM 74587V107 377 377 0.00 25 0.0000
2016-08-12 2016-06-30 13F PUMA BIOTECHNOLOGY COM 74587V107 0 -3,961 -100.00 0 -100.00
2016-05-16 2016-03-31 13F PUMA BIOTECHNOLOGY COM 74587V107 3,961 3,245 453.21 115 105.36 0.0002
2016-02-12 2015-12-31 13F PUMA BIOTECHNOLOGY COM 74587V107 716 -25,139 -97.23 56 -97.11 0.0001
2015-11-13 2015-09-30 13F PUMA BIOTECHNOLOGY COM 74587V107 25,855 14,647 130.68 1,940 49.23 0.0023
2015-08-14 2015-06-30 13F PUMA BIOTECHNOLOGY COM 74587V107 11,208 3,270 41.19 1,300 -30.63 0.0015
2015-05-19 2015-03-31 13F/A-1 PUMA BIOTECHNOLOGY COM 74587V107 7,938 -7,404 -48.26 1,874 -35.38 0.0022
2015-05-14 2015-03-31 13F PUMA BIOTECHNOLOGY COM 74587V107 7,938 1,874
2015-02-13 2014-12-31 13F PUMA BIOTECHNOLOGY COM 74587V107 15,342 -30,423 -66.48 2,900 -73.37 0.0028
2014-11-14 2014-09-30 13F PUMA BIOTECHNOLOGY COM 74587V107 45,765 -109,162 -70.46 10,892 6.52 0.0105
2014-08-14 2014-06-30 13F PUMA BIOTECHNOLOGY COM 74587V107 154,927 148,736 2,402.46 10,225 1,487.73 0.0108
2014-05-15 2014-03-31 13F PUMA BIOTECHNOLOGY COM 74587V107 6,191 -990 -13.79 644 -12.97 0.0007
2014-02-13 2013-12-31 13F PUMA BIOTECHNOLOGY COM 74587V107 7,181 6,116 574.27 740 1,198.25 0.0008
2013-11-14 2013-09-30 13F PUMA BIOTECHNOLOGY COM 74587V107 1,065 -96 -8.27 57 9.62 0.0001
2013-08-14 2013-06-30 13F PUMA BIOTECHNOLOGY COM 74587V107 1,161 1,161 52 0.0001
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2020-05-13 2020-03-31 13F PUMA BIOTECHNOLOGY OPT Call 0 -100.00 0 -100.00 n/a n/a n/a
2020-02-10 2019-12-31 13F PUMA BIOTECHNOLOGY OPT Call 1,500 0.00 13 -18.75 n/a n/a n/a
2019-11-15 2019-09-30 13F/A PUMA BIOTECHNOLOGY OPT Call 1,500 16 n/a n/a n/a
2019-11-14 2019-09-30 13F PUMA BIOTECHNOLOGY OPT Call 1,500 16 n/a n/a n/a
2019-05-15 2019-03-31 13F PUMA BIOTECHNOLOGY OPT Call 0 -100.00 0 -100.00 n/a n/a n/a
2019-02-14 2018-12-31 13F PUMA BIOTECHNOLOGY OPT Call 1,200 -57.14 24 -81.25 n/a n/a n/a
2018-11-14 2018-09-30 13F PUMA BIOTECHNOLOGY OPT Call 2,800 -95.33 128 -96.39 n/a n/a n/a
2018-08-14 2018-06-30 13F PUMA BIOTECHNOLOGY OPT Call 60,000 5,354.55 3,549 4,632.00 n/a n/a n/a
2018-05-15 2018-03-31 13F PUMA BIOTECHNOLOGY OPT Call 1,100 -95.80 75 -97.10 n/a n/a n/a
2018-02-14 2017-12-31 13F PUMA BIOTECHNOLOGY OPT Call 26,200 13,000.00 2,590 10,691.67 n/a n/a n/a
2017-11-14 2017-09-30 13F PUMA BIOTECHNOLOGY OPT Call 200 -96.30 24 -94.92 n/a n/a n/a
2017-08-14 2017-06-30 13F PUMA BIOTECHNOLOGY OPT Call 5,400 2,600.00 472 6,642.86 n/a n/a n/a
2017-05-15 2017-03-31 13F PUMA BIOTECHNOLOGY OPT Call 200 -94.87 7 -94.17 n/a n/a n/a
2017-02-14 2016-12-31 13F PUMA BIOTECHNOLOGY OPT Call 3,900 120 n/a n/a n/a
2015-11-13 2015-09-30 13F PUMA BIOTECHNOLOGY OPT Call 0 -100.00 0 -100.00 n/a n/a n/a
2015-08-14 2015-06-30 13F PUMA BIOTECHNOLOGY OPT Call 90,000 10,440 n/a n/a n/a
2014-11-14 2014-09-30 13F PUMA BIOTECHNOLOGY OPT Call 0 -100.00 0 -100.00 n/a n/a n/a
2014-08-14 2014-06-30 13F PUMA BIOTECHNOLOGY OPT Call 77,900 1,243.10 5,142 1,574.92 n/a n/a n/a
2014-02-13 2013-12-31 13F PUMA BIOTECHNOLOGY OPT Call 0 -100.00 0 -100.00 n/a n/a n/a
2013-11-14 2013-09-30 13F PUMA BIOTECHNOLOGY OPT Call 5,800 307 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2019-08-14 2019-06-30 13F PUMA BIOTECHNOLOGY OPT Put 0 -100.00 0 -100.00 n/a n/a n/a
2019-05-15 2019-03-31 13F PUMA BIOTECHNOLOGY OPT Put 5,000 -47.92 194 -0.51 n/a n/a n/a
2019-02-14 2018-12-31 13F PUMA BIOTECHNOLOGY OPT Put 9,600 195 n/a n/a n/a
2018-11-14 2018-09-30 13F PUMA BIOTECHNOLOGY OPT Put 0 -100.00 0 -100.00 n/a n/a n/a
2018-08-14 2018-06-30 13F PUMA BIOTECHNOLOGY OPT Put 200 -92.59 12 -93.48 n/a n/a n/a
2018-05-15 2018-03-31 13F PUMA BIOTECHNOLOGY OPT Put 2,700 -95.47 184 -96.88 n/a n/a n/a
2018-02-14 2017-12-31 13F PUMA BIOTECHNOLOGY OPT Put 59,600 99.33 5,892 64.54 n/a n/a n/a
2017-11-14 2017-09-30 13F PUMA BIOTECHNOLOGY OPT Put 29,900 -42.50 3,581 -21.21 n/a n/a n/a
2017-08-14 2017-06-30 13F PUMA BIOTECHNOLOGY OPT Put 52,000 4,233.33 4,545 10,000.00 n/a n/a n/a
2017-05-15 2017-03-31 13F PUMA BIOTECHNOLOGY OPT Put 1,200 45 n/a n/a n/a
2015-08-14 2015-06-30 13F PUMA BIOTECHNOLOGY OPT Put 0 -100.00 0 -100.00 n/a n/a n/a
2015-05-19 2015-03-31 13F/A PUMA BIOTECHNOLOGY OPT Put 8,900 -42.21 2,100 -27.86 n/a n/a n/a
2015-05-14 2015-03-31 13F PUMA BIOTECHNOLOGY OPT Put 8,900 2,100 n/a n/a n/a
2015-02-13 2014-12-31 13F PUMA BIOTECHNOLOGY OPT Put 15,400 -74.88 2,911 -80.05 n/a n/a n/a
2014-11-14 2014-09-30 13F PUMA BIOTECHNOLOGY OPT Put 61,300 14,589 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.